208 related articles for article (PubMed ID: 16193465)
1. Apparently low maternal serum inhibin A levels in second-trimester screening.
Lambert-Messerlian GM; Keren DF; Raphtis CS; Byberg K; Canick JA
Prenat Diagn; 2005 Oct; 25(10):967-8. PubMed ID: 16193465
[No Abstract] [Full Text] [Related]
2. Second trimester serum markers.
Canick JA; MacRae AR
Semin Perinatol; 2005 Aug; 29(4):203-8. PubMed ID: 16104669
[TBL] [Abstract][Full Text] [Related]
3. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
4. Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers.
Hackshaw AK; Wald NJ
Prenat Diagn; 2001 Jan; 21(1):58-61. PubMed ID: 11180243
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester prenatal screening markers for Down syndrome in women with insulin-dependent diabetes mellitus.
Huttly W; Rudnicka A; Wald NJ
Prenat Diagn; 2004 Oct; 24(10):804-7. PubMed ID: 15503275
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
Cuckle HS; Holding S; Jones R
Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
[TBL] [Abstract][Full Text] [Related]
7. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
Wald NJ; Watt HC; George L
Prenat Diagn; 1996 Oct; 16(10):923-6. PubMed ID: 8938061
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum inhibin-A levels in twin pregnancies: implications for screening for Down's syndrome.
Watt HC; Wald NJ; George L
Prenat Diagn; 1996 Oct; 16(10):927-9. PubMed ID: 8938062
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Lambert-Messerlian GM; Canick JA
Semin Reprod Med; 2004 Aug; 22(3):235-42. PubMed ID: 15319826
[TBL] [Abstract][Full Text] [Related]
11. Predicting the result of additional second-trimester markers from a woman's first-trimester marker profile: a new concept in Down syndrome screening.
Maymon R; Cuckle H; Jones R; Reish O; Sharony R; Herman A
Prenat Diagn; 2005 Dec; 25(12):1102-6. PubMed ID: 16231324
[TBL] [Abstract][Full Text] [Related]
12. Screening for Down's syndrome.
Chard T
Clin Endocrinol (Oxf); 1996 Jan; 44(1):15. PubMed ID: 8706287
[No Abstract] [Full Text] [Related]
13. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies.
Rice JD; McIntosh SF; Halstead AC
Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658
[TBL] [Abstract][Full Text] [Related]
14. Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis.
Benn PA; Egan JF; Ingardia CJ
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):262-5. PubMed ID: 12375682
[TBL] [Abstract][Full Text] [Related]
15. Second trimester prenatal screening for Down syndrome: the associations between the levels of serum markers in successive pregnancies.
Huang T; Boucher K; Summers AM
Prenat Diagn; 2007 Dec; 27(12):1138-42. PubMed ID: 17960787
[TBL] [Abstract][Full Text] [Related]
16. Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy.
Brown LF; Shearing CH; Tydeman G
Ann Clin Biochem; 2011 Jan; 48(Pt 1):72-4. PubMed ID: 21115569
[TBL] [Abstract][Full Text] [Related]
17. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Lambert-Messerlian GM; Saller DN; Tumber MB; French CA; Peterson CJ; Canick JA
Prenat Diagn; 1998 Oct; 18(10):1061-7. PubMed ID: 9826898
[TBL] [Abstract][Full Text] [Related]
19. Stability of first- and second-trimester serum markers after storage and shipment.
Lambert-Messerlian GM; Eklund EE; Malone FD; Palomaki GE; Canick JA; D'Alton ME
Prenat Diagn; 2006 Jan; 26(1):17-21. PubMed ID: 16378319
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Summers AM; Huang T; Wyatt PR
Prenat Diagn; 2002 Mar; 22(3):269-71. PubMed ID: 11920909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
